TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024
TransMedics Group, Inc. (Nasdaq: TMDX), a medical technology company focused on transforming organ transplant therapy, has announced that it will release its third quarter 2024 financial results after market close on Monday, October 28, 2024. The company will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT on the same day to discuss the results.
Investors can participate in the conference call by dialing (844) 481-2832 for domestic callers or (412) 317-1852 for international callers and requesting to join the TransMedics call. Additionally, a live and archived webcast of the event will be available on the company's investor relations website at https://investors.transmedics.com/.
TransMedics Group, Inc. (Nasdaq: TMDX), un'azienda di tecnologia medica focalizzata sulla trasformazione della terapia di trapianto d'organo, ha annunciato che pubblicherà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato il lunedì 28 ottobre 2024. L'azienda ospiterà una conference call alle 4:30 p.m. ET / 1:30 p.m. PT nello stesso giorno per discutere i risultati.
Gli investitori possono partecipare alla conference call componendo il (844) 481-2832 per le chiamate domestiche oppure il (412) 317-1852 per le chiamate internazionali e richiedendo di unirsi alla chiamata di TransMedics. Inoltre, una trasmissione web in diretta e archiviata dell'evento sarà disponibile sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo https://investors.transmedics.com/.
TransMedics Group, Inc. (Nasdaq: TMDX), una empresa de tecnología médica centrada en transformar la terapia de trasplante de órganos, ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el lunes 28 de octubre de 2024. La empresa llevará a cabo una conferencia telefónica a las 4:30 p.m. ET / 1:30 p.m. PT el mismo día para discutir los resultados.
Los inversores pueden participar en la conferencia telefónica marcando (844) 481-2832 para llamadas nacionales o (412) 317-1852 para llamadas internacionales y solicitando unirse a la llamada de TransMedics. Además, una transmisión web en vivo y grabada del evento estará disponible en el sitio web de relaciones con los inversores de la empresa en https://investors.transmedics.com/.
TransMedics Group, Inc. (Nasdaq: TMDX)는 장기 이식 요법의 변화를 목표로 하는 의료 기술 회사로, 2024년 3분기 재무 결과를 2024년 10월 28일 월요일 시장 종료 후 발표할 것임을 발표했습니다. 이 회사는 같은 날 오후 4시 30분 ET / 오후 1시 30분 PT에 결과를 논의하기 위한 전화 회의를 개최할 예정입니다.
투자자는 국내 발신자는 (844) 481-2832, 국제 발신자는 (412) 317-1852로 전화하여 TransMedics 회의에 참여할 수 있습니다. 또한, 이 이벤트의 실시간 및 기록된 웹캐스트가 회사의 투자자 관계 웹사이트 https://investors.transmedics.com/에서 제공됩니다.
TransMedics Group, Inc. (Nasdaq: TMDX), une entreprise de technologie médicale axée sur la transformation de la thérapie de transplantation d'organes, a annoncé qu'elle publierait ses résultats financiers du troisième trimestre 2024 après la fermeture du marché le lundi 28 octobre 2024. L'entreprise tiendra une conférence téléphonique à 16h30 ET / 13h30 PT le même jour pour discuter des résultats.
Les investisseurs peuvent participer à la conférence téléphonique en composant le (844) 481-2832 pour les appelants nationaux ou le (412) 317-1852 pour les appelants internationaux et en demandant à rejoindre l'appel de TransMedics. De plus, un webcast en direct et archivé de l'événement sera disponible sur le site Web des relations investisseurs de l'entreprise à l'adresse https://investors.transmedics.com/.
TransMedics Group, Inc. (Nasdaq: TMDX), ein Medizintechnikunternehmen, das sich auf die Transformation der Organtransplantationstherapie konzentriert, hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 nach Marktschluss am Montag, den 28. Oktober 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr ET / 13:30 Uhr PT eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie (844) 481-2832 für nationale Anrufer oder (412) 317-1852 für internationale Anrufer anrufen und um die Teilnahme an der TransMedics-Anruf bitten. Außerdem wird eine Live- und archivierte Webcast der Veranstaltung auf der Investoren-Relations-Website des Unternehmens unter https://investors.transmedics.com/ verfügbar sein.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing (844) 481-2832 for domestic callers or (412) 317-1852 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-third-quarter-2024-financial-results-on-october-28-2024-302276974.html
SOURCE TransMedics Group, Inc.
FAQ
When will TransMedics (TMDX) release its Q3 2024 financial results?
What time is the TransMedics (TMDX) Q3 2024 earnings conference call?
How can investors listen to TransMedics' (TMDX) Q3 2024 earnings call?
Where can I find the webcast for TransMedics' (TMDX) Q3 2024 earnings call?
